Plasma Fractionation Market by Product - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

  • Single User License $3500

Plasma Fractionation Market by Product - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Status : October, 2020 | Pharmaceutical | PPT format

Report Digest


Global Plasma Fractionation Market: Snapshot

Plasma, which comprises of roughly 55% of blood by volume, consists of a number of different proteins numbering into the thousands, and other substances such as hormones, minerals, etc. Plasma renders a large number of therapeutic uses due to the number of proteins present in plasma. For instance, Albumin, which is commonly used to rejuvenate and maintain blood volume after traumatic injury, during surgery and during the exchange of plasma. Plasma fractionation is a process wherein the different components of blood plasma (a part of blood obtained by blood fractionation) are separated. It acts as a natural raw material which is used in various kinds of life-saving treatments and medications.

Plasma fractionation is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation. Increasing use of immunoglobulin in therapeutic areas and prevalence of emphysema & AATD are factors fueling the growth of the world plasma fractionation market.

However, the high cost of plasma products, limited reimbursement availability, the significantly adverse side effects associated with these products, along with the emergence of recombinant products (which can be used as an alternative to plasma products) are restraining the growth of the plasma fractionation market. Moreover, high infrastructural costs associate with production, fixed manufacturing costs, and stringent government regulations for plasma products are further restraining the plasma fractionation market growth.

Global Plasma Fractionation Market: Overview

The global plasma fractionation market is envisaged to develop at a brisk pace owing to the rising geriatric population all over the world. This is mainly due to the surging use of immunoglobins for various therapeutic treatment processes undertaken for providing adequate healthcare to elderly people.

Global Plasma Fractionation Market: Key Drivers and Restraints

A rise in healthcare awareness amongst people all over the world has been a significant driver for the global plasma fractionation market. The process which deals with separation of plasma components, finds a great requirement for treating deadly disorders caused by immunologic deficiencies, infections, and trauma. This requirement is one of the most important drivers for the plasma fractionation market. Rising cases of protein deficiency, especially in underdeveloped regions is a second factor that requires carrying out plasma fractionation to treat the deficiency symptoms. Industrial processes also require incorporating plasma fractionation to manufacture packaging materials. As the industrial sector is experiencing growth in almost all parts the world, the increasing demand for packaging material is contributing towards a positive graph of the global plasma fractionation market. Various treatment processes need the inactivation of viruses and prions, which are chief attributes of plasma fractionation processes. A need for enabling these attributes in the field of molecular biology and associated healthcare practices is largely responsible of the global plasma fractionation market to see a better future.

However, high cost of implementing the initial procedures is a predominant restraint that has been greatly affecting the market. Such cost issues might discourage patients from opting for treatment procedures, thus exhibiting a dampening effect on the global plasma fractionation market. Nevertheless, new regulations amended by governmental bodies all over the world promise to reduce the effects of these restraints, thus predicting a bright future for the global plasma fractionation market.

Global Plasma Fractionation Market: Geographical Outlook

Geography-wise, five regions account for the expansion of the global plasma fractionation market, viz. Asia Pacific, Europe, North America, Latin America, and Middle East and Africa. Among these, North America has emerged as a prominent regional segment with leading market shares. This is mainly due to the increasing use of prophylaxis treatment techniques in this region, along with high employment of immunoglobulins to treat neurological diseases in patients. Prophylaxis treatment as well as immunoglobulins are a crucial part of the processes needed to treat associated maladies. This region also has accounted for rise in the number of haemophilic patients, where a need for plasma fractionation is necessary, thus leading towards increased use the necessary devices in the market.

Global Plasma Fractionation Market: Competitive Analysis

As the global plasma fractionation market is still in its nascent stages, a decent yet healthy competitive landscape exists over there. Most of the companies who develop plasma fractionation techniques have embraced prominent strategies such as agreements, collaborations, partnerships, and expansions improve their image as well as presence in this market. The market players are also focusing on improving their product portfolio by extensively working on streamlining the technology used for fractionation processes. Some of the major players in the global plasma fractionation market are: Green Cross Corporation, CSL, Octapharma, Bio Product Laboratory, Grifols, Kedrion, China Biologic Products, Shanghai RAAS Blood Products, Japan Blood Products Organization, amidst many others.

Lastly, the global plasma fractionation market could be broadly divided into various segments based on products, application, end users, and regional analysis. Under applications, the plasma fractionation market showcases neurology is expected hold a leading segment position, as a result of attracting maximum preference and consequent revenue. This could be due to the surging utilization of IVIG in the treatment of various neurological diseases, especially concerning cases that involve the central and peripheral nervous systems.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?